UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | H | J | L | M | S | T | V | W
Number of items: 47.

A

Abbasi, AM; Chester, KA; MacPherson, AJS; Boxer, G; Begent, RHJ; Malcolm, ADB; (1991) Comparison of messenger-RNA and protein expression for carcinoembryonic antigen(CEA)in tissue-section of normal colorectal mucosa and colonic adenocarcinoma. In: (pp. A176-A176).

B

BAGSHAWE, KD; SHARMA, SK; SOUTHALL, PJ; BODEN, JA; BOXER, GM; PATRIDGE, TA; ANTONIW, P; (1991) SELECTIVE UPTAKE OF TOXIC NUCLEOSIDE (I-125UDR) BY RESISTANT CANCER. BRIT J RADIOL , 64 (757) 37 - 44.

BAGSHAWE, KD; SHARMA, SK; SPRINGER, CJ; ANTONIW, P; BODEN, JA; ROGERS, GT; BURKE, PJ; ... SHERWOOD, RF; + view all (1991) ANTIBODY DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - CLINICAL REPORT. In: (Proceedings) WORKSHOP ON MONOCLONAL ANTIBODIES IN BREAST AND OVARIAN CANCER. (pp. pp. 233-238). ASFRA

BAGSHAWE, KD; SHARMA, SK; SPRINGER, CJ; ANTONIW, P; ROGERS, GT; BURKE, PJ; MELTON, R; (1991) ANTIBODY-ENZYME CONJUGATES CAN GENERATE CYTOTOXIC DRUGS FROM INACTIVE PRECURSORS AT TUMOR SITES. ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS , 4 (4) pp. 915-922.

BAKER, SR; MICHIE, CA; SOO, KS; WYLLIE, JH; BEVERLEY, PCL; (1991) LYMPHOPENIA IN DIVERTICULITIS. LANCET , 338 (8766) 569 - 570.

BEYAERT, R; DEPOTTER, C; VANHAESEBROECK, B; VANROY, F; FIERS, W; (1991) INDUCTION OF INFLAMMATORY CELL INFILTRATION AND NECROSIS IN NORMAL MOUSE SKIN BY THE COMBINED TREATMENT OF TUMOR-NECROSIS-FACTOR AND LITHIUM-CHLORIDE. AMERICAN JOURNAL OF PATHOLOGY , 138 (3) pp. 727-739.

BOWER, M; COLSTON, KW; STEIN, RC; HEDLEY, A; GAZET, JC; FORD, HT; COOMBES, RC; (1991) TOPICAL CALCIPOTRIOL TREATMENT IN ADVANCED BREAST-CANCER. LANCET , 337 (8743) pp. 701-702. 10.1016/0140-6736(91)90280-3.

BOWER, M; STEIN, RC; HEDLEY, A; DAVENPORT, J; COLSTON, K; COOMBES, RC; (1991) THE USE OF NASAL CALCITONIN SPRAY IN THE TREATMENT OF HYPERCALCEMIA OF MALIGNANCY. CANCER CHEMOTHERAPY AND PHARMACOLOGY , 28 (4) pp. 311-312.

C

CALVERT, AH; (1991) COMBINING CISPLATIN AND CARBOPLATIN COMPLEMENTARY OR CONTRADICTORY. ANN ONCOL , 2 (2) 89 - 91.

CALVERT, AH; NEWELL, DR; BALMANNO, K; PEARSON, AD; PRICE, L; KIER, M; (1991) PHARMACOKINETICS OF CARBOPLATIN IN CHILDREN AND THE DEVELOPMENT OF A PEDIATRIC DOSE EQUATION. PLATINUM AND OTHER METAL COORDINATION COMPOUNDS IN CANCER CHEMOTHERAPY 335 - 343.

CALVERT, AH; URIE, J; (1991) THE COSTS OF CARBOPLATIN TREATMENT. SEMIN ONCOL , 18 (1) 28 - 31.

D

DAWSON, PM; BLAIR, SD; BEGENT, RHJ; KELLY, AMB; BOXER, GM; THEODOROU, NA; (1991) THE VALUE OF RADIOIMMUNOGUIDED SURGERY IN 1ST AND 2ND LOOK LAPAROTOMY FOR COLORECTAL-CANCER. DIS COLON RECTUM , 34 (3) 217 - 222.

Davis, CL; Whelan, JS; Leahy, M; MacCullum, P; Norton, AJ; Amess, JAL; Rohatiner, AZS; (1991) Intermediate dose cytosine arabinoside and etoposide for the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma. In:

E

EVANS, C; STEIN, RC; DAVENPORT, J; DOUGHERTY, L; CARRUTHERS, L; COOMBES, RC; (1991) COMPARISON OF ONDANSETRON WITH DEXAMETHASONE AND DOMPERIDONE IN THE PROPHYLAXIS OF NON-CISPLATIN CHEMOTHERAPY INDUCED EMESIS REFRACTORY TO DEXAMETHASONE. EUROPEAN JOURNAL OF CANCER , 27 (3) pp. 302-303. 10.1016/0277-5379(91)90532-I.

F

FRY, AM; CHRESTA, CM; DAVIES, SM; WALKER, MC; HARRIS, AL; HARTLEY, JA; MASTERS, JRW; (1991) RELATIONSHIP BETWEEN TOPOISOMERASE-II LEVEL AND CHEMOSENSITIVITY IN HUMAN TUMOR-CELL LINES. CANCER RES , 51 (24) 6592 - 6595.

H

HARMSEN, MC; TOLNER, B; KRAM, A; GO, SJ; DEHAAN, A; WESSELS, JGH; (1991) SEQUENCES OF 3 DSRNAS ASSOCIATED WITH LA FRANCE DISEASE OF THE CULTIVATED MUSHROOM (AGARICUS-BISPORUS). CURR GENET , 20 (1-2) 137 - 144.

HAYNES, BP; JARMAN, M; DOWSETT, M; MEHTA, A; LONNING, PE; GRIGGS, LJ; JONES, A; ... COOMBES, RC; + view all (1991) PHARMACOKINETICS AND PHARMACODYNAMICS OF THE AROMATASE INHIBITOR 3-ETHYL-3-(4-PYRIDYL)PIPERIDINE-2,6-DIONE IN PATIENTS WITH POSTMENOPAUSAL BREAST-CANCER. CANCER CHEMOTHERAPY AND PHARMACOLOGY , 27 (5) pp. 367-372. 10.1007/BF00688859.

HOCHHAUSER, D; HARRIS, AL; (1991) DRUG-RESISTANCE. BRIT MED BULL , 47 (1) 178 - 196.

HUMM, JL; BAGSHAWE, KD; SHARMA, SK; BOXER, G; (1991) TISSUE DOSE ESTIMATES FOLLOWING THE SELECTIVE UPTAKE OF I-125UDR AND OTHER RADIOLABELED THYMIDINE PRECURSORS IN RESISTANT TUMORS. BRITISH JOURNAL OF RADIOLOGY , 64 (757) pp. 45-49. 10.1259/0007-1285-64-757-45.

J

JACKMAN, AL; MARSHAM, PR; MORAN, RG; KIMBELL, R; OCONNOR, BM; HUGHES, LR; CALVERT, AH; (1991) THYMIDYLATE SYNTHASE INHIBITORS - THE INVITRO ACTIVITY OF A SERIES OF HETEROCYCLIC BENZOYL RING MODIFIED 2-DESAMINO-2-METHYL-N-10-SUBSTITTED-5,8-DIDEAZAFOLATES. ADV ENZYME REGUL , 31 13 - 27.

JACKMAN, AL; MARSHAM, PR; MORAN, RG; KIMBELL, R; OCONNOR, BM; HUGHES, LR; CALVERT, AH; (1991) THYMIDYLATE SYNTHASE INHIBITORS - THE INVITRO ACTIVITY OF A SERIES OF HETEROCYCLIC BENZOYL RING MODIFIED 2-DESAMINO-2-METHYL-N-10-SUBSTITTED-5,8-DIDEAZAFOLATES. ADVANCES IN ENZYME REGULATION, VOL 31 , 31 13 - 27.

JACKMAN, AL; NEWELL, DR; GIBSON, W; JODRELL, DI; TAYLOR, GA; BISHOP, JA; HUGHES, LR; (1991) THE BIOCHEMICAL PHARMACOLOGY OF THE THYMIDYLATE SYNTHASE INHIBITOR, 2-DESAMINO-2-METHYL-N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID (ICI-198583). BIOCHEM PHARMACOL , 42 (10) 1885 - 1895.

JACKMAN, AL; TAYLOR, GA; GIBSON, W; KIMBELL, R; BROWN, M; CALVERT, AH; JUDSON, IR; (1991) ICI-D1694, A QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR THAT IS A POTENT INHIBITOR OF L1210 TUMOR-CELL GROWTH-INVITRO AND INVIVO - A NEW AGENT FOR CLINICAL-STUDY. CANCER RES , 51 (20) 5579 - 5586.

JACKSON, C; HARTLEY, JA; JENKINS, TC; GODFREY, R; SAUNDERS, R; THURSTON, DE; (1991) N-2,N-4,N-6-TRI(HYDROXYMETHYL)-N-2,N-4,N-6-TRIMETHYLMELAMINE (TRIMELAMOL) IS AN EFFICIENT DNA CROSS-LINKING AGENT INVITRO. BIOCHEMICAL PHARMACOLOGY , 42 (11) pp. 2091-2097. 10.1016/0006-2952(91)90343-4.

JODRELL, D; FORREST, A; HAWTOF, J; GRAHAM, M; CALVERT, AH; EGORIN, M; (1991) THE POPULATION PHARMACOKINETICS OF CI941, A NOVEL ANTHRAPYRAZOLE ANTICANCER AGENT. CLIN PHARMACOL THER , 49 (2) 195 - 195.

JODRELL, DI; NEWELL, DR; GIBSON, W; HUGHES, LR; CALVERT, AH; (1991) THE PHARMACOKINETICS OF THE QUINAZOLINE ANTIFOLATE ICI D1694 IN MICE AND RATS. CANCER CHEMOTH PHARM , 28 (5) 331 - 338.

JODRELL, DI; NEWELL, DR; MORGAN, SE; CLINTON, S; BENSTED, JPM; HUGHES, LR; CALVERT, AH; (1991) THE RENAL EFFECTS OF N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID (CB3717) AND A NON-NEPHROTOXIC ANALOG ICI D1694, IN MICE. BRIT J CANCER , 64 (5) 833 - 838.

JUDSON, IR; CALVERT, AH; GORE, ME; BALMANNO, K; GUMBRELL, LA; PERREN, T; WILTSHAW, E; (1991) PHASE-II TRIAL OF TRIMELAMOL IN REFRACTORY OVARIAN-CANCER. BRIT J CANCER , 63 (2) 311 - 313.

L

LEENHOUTS, KJ; TOLNER, B; BRON, S; KOK, J; VENEMA, G; SEEGERS, JFML; (1991) NUCLEOTIDE-SEQUENCE AND CHARACTERIZATION OF THE BROAD-HOST-RANGE LACTOCOCCAL PLASMID PWVO1. PLASMID , 26 (1) 55 - 66.

M

MARSHAM, PR; HUGHES, LR; JACKMAN, AL; HAYTER, AJ; OLDFIELD, J; WARDLEWORTH, JM; BISHOP, JAM; ... CALVERT, AH; + view all (1991) QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITORS - HETEROCYCLIC BENZOYL RING MODIFICATIONS. J MED CHEM , 34 (5) 1594 - 1605.

MARSHAM, PR; JACKMAN, AL; HAYTER, AJ; DAW, MR; SNOWDEN, JL; OCONNOR, BM; BISHOP, JAM; ... HUGHES, LR; + view all (1991) QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITORS - BRIDGE MODIFICATIONS AND CONFORMATIONALLY RESTRICTED ANALOGS IN THE C2-METHYL SERIES. J MED CHEM , 34 (7) 2209 - 2218.

S

SHARMA, SK; BAGSHAWE, KD; SPRINGER, CJ; BURKE, PJ; ROGERS, GT; BODEN, JA; ANTONIW, P; ... SHERWOOD, RF; + view all (1991) ANTIBODY DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - A 3 PHASE SYSTEM. In: (Proceedings) WORKSHOP ON MONOCLONAL ANTIBODIES IN BREAST AND OVARIAN CANCER. (pp. pp. 225-231). ASFRA

SPRINGER, CJ; BAGSHAWE, KD; SHARMA, SK; SEARLE, F; BODEN, JA; ANTONIW, P; BURKE, PJ; ... MELTON, RG; + view all (1991) ABLATION OF HUMAN CHORIOCARCINOMA XENOGRAFTS IN NUDE-MICE BY ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) WITH 3 NOVEL COMPOUNDS. EUROPEAN JOURNAL OF CANCER , 27 (11) pp. 1361-1366. 10.1016/0277-5379(91)90010-B.

STEIN, RC; CANNON, S; CASSONI, A; PRINGLE, JS; STOKER, DJ; SOUHAMI, RL; (1991) CLINICAL ONCOLOGY - CASE PRESENTATIONS FROM ONCOLOGY CENTERS .1. EWINGS-SARCOMA - THE LONDON BONE-TUMOR SERVICE. EUROPEAN JOURNAL OF CANCER , 27 (11) pp. 1525-1533. 10.1016/0277-5379(91)90042-C.

STEIN, RC; MALKOVSKA, V; MORGAN, S; GALAZKA, A; ANISZEWSKI, C; ROY, SE; SHEARER, RJ; ... COOMBES, RC; + view all (1991) THE CLINICAL EFFECTS OF PROLONGED TREATMENT OF PATIENTS WITH ADVANCED CANCER WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2. BRITISH JOURNAL OF CANCER , 63 (2) pp. 275-278. 10.1038/bjc.1991.64.

SUFFYS, P; BEYAERT, R; DEVALCK, D; VANHAESEBROECK, B; VANROY, F; FIERS, W; (1991) TUMOR-NECROSIS-FACTOR-MEDIATED CYTOTOXICITY IS CORRELATED WITH PHOSPHOLIPASE-A2 ACTIVITY, BUT NOT WITH ARACHIDONIC-ACID RELEASE PER-SE. EUROPEAN JOURNAL OF BIOCHEMISTRY , 195 (2) pp. 465-475. 10.1111/j.1432-1033.1991.tb15727.x.

Stein, RC; (1991) Initial studies of 4-hydroxyandrostenedione in premenopausal patients with advanced breast cancer. In: Coombes, RC and Dowsett, M, (eds.) 4-hydroxyandrostenedione: a new approach to hormone-dependent cancer. (pp. 35-39). Royal Society of Medicine

T

TALBOT, DC; SMITH, IE; MANSI, JL; JUDSON, I; CALVERT, AH; ASHLEY, SE; (1991) ANTHRAPYRAZOLE CI941 - A HIGHLY-ACTIVE NEW AGENT IN THE TREATMENT OF ADVANCED BREAST-CANCER. J CLIN ONCOL , 9 (12) 2141 - 2147.

THORNTON, TJ; JONES, TR; JACKMAN, AL; FLINN, A; OCONNOR, BM; WARNER, P; CALVERT, AH; (1991) QUINAZOLINE ANTIFOLATES INHIBITING THYMIDYLATE SYNTHASE - 4-THIO-SUBSTITUTED ANALOGS. J MED CHEM , 34 (3) 978 - 984.

V

VANHAESEBROECK, B; MAREEL, M; VANROY, F; GROOTEN, J; FIERS, W; (1991) EXPRESSION OF THE TUMOR-NECROSIS-FACTOR GENE IN TUMOR-CELLS CORRELATES WITH REDUCED TUMORIGENICITY AND REDUCED INVASIVENESS INVIVO. CANCER RESEARCH , 51 (8) pp. 2229-2238.

VANHAESEBROECK, B; VANBLADEL, S; LENAERTS, A; SUFFYS, P; BEYAERT, R; LUCAS, R; VANROY, F; (1991) 2 DISCRETE TYPES OF TUMOR NECROSIS FACTOR-RESISTANT CELLS DERIVED FROM THE SAME CELL-LINE. CANCER RESEARCH , 51 (9) pp. 2469-2477.

VYAKARNAM, A; MATEAR, PM; CRANENBURG, C; MICHIE, C; BEVERLEY, PCL; WAHREN, B; GILL, SK; (1991) T-CELL RESPONSES TO PEPTIDES COVERING THE GAG P24 REGION OF HIV-1 OCCUR IN HIV-1 SERONEGATIVE INDIVIDUALS. INT IMMUNOL , 3 (10) 939 - 947.

Vanhaesebroeck, B; Van Bladel, S; Lenaerts, A; Suffys, P; Beyaert, R; Lucas, R; Van Roy, F; (1991) Two discrete types of tumor necrosis factor-resistant cells derived from the same cell line. Cancer Res , 51 (9) pp. 2469-2477.

W

WHITE, LA; NOBLES, JA; LEE, M; HARTLEY, JA; (1991) SYNTHESIS OF AN AMIDINE LINKED ANALOG OF DISTAMYCIN-A AND ITS DNA-BINDING PROPERTIES. In: (pp. 77-ORGN). AMER CHEMICAL SOC

Whelan, JS; Davis, CL; Rule, S; Ranson, M; Smith, OP; Mehta, AB; Catovsky, D; ... Lister, TA; + view all (1991) Fludarabine phosphate for the treatment of low grade lymphoid malignancy. Br J Cancer , 64 (1) pp. 120-123. 10.1038/bjc.1991.253.

Whelan, JS; Phear, GA; Rohatiner, AZS; Lister, TA; Meuth, M; (1991) DNA sequence determination of CTP synthetase mutations in ara C-resistant hamster cells. In:

Whelan, JS; Reznek, RH; Daniell, SJ; Norton, AJ; Lister, TA; Rohatiner, AZ; (1991) Computed tomography (CT) and ultrasound (US) guided core biopsy in the management of non-Hodgkin's lymphoma. Br J Cancer , 63 (3) pp. 460-462. 10.1038/bjc.1991.107.

This list was generated on Sun Jun 16 05:07:32 2019 BST.